drugset / Trial / NCT01970059
A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of present study is to evaluate the efficacy and safety of Extended-Release Carvedilol Sulfate versus in Patients With Mild or Moderate Primary Hypertension
Timeline
- Start
- 2013-10
- Primary completion
- 2013-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 18 mg | Oral |
| Subject | Carvedilol | Other / unclassified | 72 mg | Oral |
| Comparator | Metoprolol | Other / unclassified | 47.5 mg | Oral |
| Comparator | Metoprolol | Other / unclassified | 190 mg | Oral |